ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
68,305.35
0.86%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Anthera Pharmaceuticals Inc (CE) (ANTH)

  7. Anthera Pharmaceuticals Inc (CE) (ANTH) News

ANTH

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ANTH
DateTimeSourceHeadlineSymbolCompany
09/12/20182:21PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/30/20183:45PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/27/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:28PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:28PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:28PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:26PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:24PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:24PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:23PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:23PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:22PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:21PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/20/20183:06PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/17/20181:38PMEdgar (US Regulatory)(25)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
07/09/20184:08PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
06/27/20183:14PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
06/27/20187:00AMGlobeNewswire Inc.Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
06/18/20183:32PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ANTH

Your Recent History

BOV
CRPT11
Cripto20 Empci
BIT
OVS
Ovs
BIT
GS0207
GOLDMAN SACHS
BIT
P77138
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved